Koyfin Home > Directory > Health Care > Aratana Theraptcs > EBITDA

Aratana Theraptcs EBITDA Chart (PETX)

Aratana Theraptcs annual/quarterly EBITDA from 2013 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aratana Theraptcs EBITDA for the quarter ending December 12, 2018 was $-7m a 5.76% decrease of 0m year over year
  • Aratana Theraptcs EBITDA for the last 12 months ending December 12, 2018 was $-10m a -202.44% increase of 21m year over year
  • Aratana Theraptcs Annual EBITDA for 2018 was $-10m a -244.04% increase of 25m from 2017
  • Aratana Theraptcs Annual EBITDA for 2017 was $-36m a 38.82% decrease of -14m from 2016
  • Aratana Theraptcs Annual EBITDA for 2016 was $-22m a -107.92% increase of 24m from 2015
Other Income Statement Metrics:
  • Aratana Theraptcs Net Income for the quarter ending December 12, 2018 was $-9m a 1.00% decrease of 0m year over year
  • Aratana Theraptcs Total Revenue for the quarter ending September 09, 2018 was $22m a 51.49% increase of 11m year over year
View Chart On Koyfin

Quarterly PETX EBITDA Data

12/2018$-7m
09/2018$10m
06/2018$-5m
03/2018$-7m
12/2017$-7m
09/2017$-8m
06/2017$-9m
03/2017$-11m
12/2016$-17m
09/2016$-12m

Annual PETX EBITDA Data

2018$-10m
2017$-36m
2016$-22m
2015$-46m
2014$-37m
2013$-18m
2012$-10m